JANESVILLE, Wis., Aug. 16, 2022 – SHINE Technologies, LLC (SHINE), a next-generation fusion technology company, today announced Tom D’Orazio has joined as the CEO of Phoenix LLC (Phoenix). SHINE and Phoenix are both wholly owned subsidiaries of Illuminated Holdings, and Phoenix operates the industrial imaging arm of the business. D’Orazio succeeds Jess Giffey, who served as interim CEO and will continue in her role as General Manager of SHINE’s Systems & Manufacturing division.
D’Orazio brings more than two decades of experience in sales leadership roles for start-ups, emerging and established companies across health care, biotech and software industries. He most recently was the Chief Operating Officer for Tryp Therapeutics, a clinical-stage pharma company, where he was also a founding member. Prior to Tryp, he was CEO and President at ImmnoPrecise Antibodies, a scientific services and research organization.
D’Orazio’s leadership experience spans strategic planning, corporate partnerships, fundraising, and building sales and marketing teams.
“As a proven leader for science-driven companies, Tom will be a great addition to Phoenix,” said Greg Piefer, Founder and CEO of SHINE. “Along with the announcement of a contract with the Department of Homeland Security earlier this year, Phoenix has signed several new imaging contracts this year. With his leadership and experience, Tom will continue to build on that momentum. I’d also like to thank Jess for serving as interim CEO for the past year.”
“I’m delighted to be back in Wisconsin and working on growing an innovative service enterprise,” D’Orazio said. “The advanced technology and opportunity to help create a safer world through neutron imaging is both inspiring and exciting. I’m anxious to meet the talented team and get to work.”
D’Orazio holds a bachelor’s degree in chemistry from Loyola University of Chicago and an MBA from Vanderbilt University with concentrations in marketing and finance.
Based in Janesville, Wisconsin, SHINE deploys its safe, cost-effective and environmentally friendly fusion technology in a stepwise approach. Its systems are used to inspect industrial components in aerospace, defense, energy and other sectors. SHINE’s proprietary medical isotope production processes create non-carrier-added lutetium-177 and are expected to create molybdenum-99. In the future, SHINE plans to scale its fusion technology to help solve one of energy’s toughest hurdles by recycling nuclear waste. Through a purpose-driven and phased approach, SHINE aims to generate fusion power to deliver clean, abundant energy that could transform life on Earth. Want to learn more about SHINE? Follow us on social media @shinefusion and sign up for our email newsletter to follow us on our journey!
Media Contact: info@shinefusion.com
Phoenix is an industry leader in neutron imaging, a critical tool for nondestructive testing in aerospace, defense, health care and other industries. This testing helps manufacturers design better, more efficient, safer products, and provides quality assurance and failure analysis. Located in Fitchburg, Wisconsin, the Phoenix Neutron Imaging Center is the first facility of its kind to offer commercial neutron imaging services without the use of a reactor alongside X-ray imaging.
